ArticleAnnals of breast cancer and therapy2020

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer.

Gagan Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.